Search Results - A. A. Kurylev
- Showing 1 - 20 results of 20
-
1
What is the role of antineoplastic drug safety in reimbursement decision making? by A. S. Kolbin, A. A. Kurylev
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Determination of the reference value of the incremental cost-efficacy and cost-utility coefficient in Russia in oncology by A. S. Kolbin, A. A. Kurylev
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Analysis of effectiveness criteria in pharmacoeconomic studies of hypoglycemic drugs proposed for inclusion into the essential drug list in 2014-2016 in Russia by A. A. Mosikyan, A. A. Kurylev, A. S. Kolbin
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Comparison of clinical-economic evaluation of cabazitaxel and abiraterone for prostate cancer based on the results of clinical trials and real world data by A. S. Kolbin, A. A. Kurylev, A. V. Pavlysh
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
Overview of mathematical models of breast cancer by Yu. P. Yurkova, A. A. Kurylev, A. S. Kolbin
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
6
Analysis of the effectiveness of vaccination against COVID-19 based on real-world data in St. Petersburg by A. A. Kurylev, A. A. Zhuravkov, A. S. Kolbin
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
7
Pharmacoeconomic evaluation of ipragliflozin in combination with metformin in comparison with other regimens of therapy for type 2 diabetes mellitus by A. S. Kolbin, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
8
HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE by A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina
Published 2016Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
9
Pharmacoeconomic analysis of vemurafenib and dabrafenib use in patients with inoperable or metastatic melanoma with BRAF V600 mutation by A. S. Kolbin, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
10
CYP2D6 genotyping in the daily routine of a psychiatric hospital - pharmacoeconomic evaluation by A. A. Kurylev, B. V. Andreev, A. S. Kolbin, O. V. Limankin
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
11
An update of pharmacoeconomic analysis of trastuzumab emtanzine in patients with HER2+ breast cancer and central nervous system metastases by A. S. Kolbin, A. A. Kurylev, Y. E. Balykina, M. A. Proskurin
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
12
Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases by A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
13
Health-economic analysis of tocilizumab in patients with rheumatoid arthritis and systemic juvenile arthritis by A. S. Kolbin, A. A. Kurylev, S. A. Mishinova, Yu. E. Balykina, M. A. Proskurin
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
14
The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies by A. S. Kolbin, Yu. M. Gomon, A. R. Kasimova, A. A. Kurylev, A. E. Bem
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
15
Pharmacoeconomic analysis of trastuzumab emtanzine comparing to lapatinib + capecitabine in pa-tients with HER2+ breast cancer and central nervous system metastases by A. S. Kolbin, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, D. R. Naskhletashvili
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
16
Economic analysis of Lixisenatide in Diabetes Mellitus Type 2 by A. S. Kolbin, A. A. Mosikyan, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, W. Zhao
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
17
Modeling microbial drug-resistance: from mathematics to pharmacoeconomics by Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
18
FIRST RUSSIAN TYPE 2 DIABETES MELLITUS SIMULATION MODEL WITH DISCREET EVENTS MODELING. HEALTH-ECONOMIC ANALYSIS by A. S. Kolbin, O. K. Khmelnitskiy, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, E. P. Kolpak, M. V. Bure
Published 2015Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
19
The social-economic burden of spinal muscular atrophy in Russia by A. S. Kolbin, D. V. Vlodavets, A. A. Kurylev, Yu. Ye. Balykina, M. A. Proskurin, S. A. Mishinova, O. Yu. Germanenko, N. Yu. Kolbina
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
20
MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 by A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum
Published 2016Call Number: Loading…Connect to this object online.
Located: Loading…
Book